J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall

J&J single shot sees 66% efficacy in moderate COVID-19, 85% in severe cases; shares fall
badams
Fri, 01/29/2021 – 09:11

Published on Fri, 29 Jan 2021 14:11:05 +0000 and made possible by nintex format number as currency